Literature DB >> 232519

Preoperative estimation of operative risk in liver surgery, with special reference to functional reserve of the remnant liver following major hepatic resection.

R Mizumoto, Y Kawarada, T Noguchi.   

Abstract

Hepatic functional reserve was evaluated in 76 patients with known liver, biliary tract or pancreas diseases using kinetic analysis of removal of indocyanine green (ICG) with special reference to maximal removal rate (Rmax). In surgery other than hepatectomy, if ICG Rmax is below 0.4 mg/kg/min the operative risk should be considered high. In hepatic surgery, even if ICG Rmax is above 0.4 mg/kg/min the operative risk was high and it should be required to be above 1.0 mg/kg/min for extended lobectomy or hepatectomy. Furthermore, prior to hepatectomy the functional reserve of the remnant liver was estimated from an effective liver volume rate, calculated from the rate of uptake of radioisotope as measured by on-line computer system, and ICG Rmax. The functional reserve of the remnant liver was compared with the operative results, such as morbidity or mortality for each patient. When ICG Rmax of the remnant liver was below 0.4 mg/kg/min the prognosis was poor in hepatic surgery, because of there were three postoperative death and seven complications such as ascites or liver failure in the ten cases. On the other hand, when above 0.4 mg/kg/min, the prognosis was good without any postoperative death or complications in the twelve cases of hepatic surgery, as the completely same results for general surgery, in which it is as well when ICG Rmax of whole liver is above 0.4 mg/kg/min.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 232519     DOI: 10.1007/bf02468635

Source DB:  PubMed          Journal:  Jpn J Surg        ISSN: 0047-1909


  2 in total

1.  The determination of liver mass from radionuclide images.

Authors:  F D Rollo; F H DeLand
Journal:  Radiology       Date:  1968-12       Impact factor: 11.105

2.  Estimation of the functional reserve of human liver.

Authors:  F G Moody; L F Rikkers; J S Aldrete
Journal:  Ann Surg       Date:  1974-10       Impact factor: 12.969

  2 in total
  17 in total

1.  Clinical significance of the measurement of hepatic blood flow using xenon 133 and balloon catheter in patients undergoing treatment for hepatocellular carcinoma.

Authors:  S Miyauchi; Y Yasuhara; Y Ohta
Journal:  Eur J Nucl Med       Date:  1991

2.  Response of hepatic mitochondrial redox state to oral glucose load. Redox tolerance test as a new predictor of surgical risk in hepatectomy.

Authors:  K Mori; K Ozawa; Y Yamamoto; A Maki; Y Shimahara; N Kobayashi; Y Yamaoka; K Kumada
Journal:  Ann Surg       Date:  1990-04       Impact factor: 12.969

3.  Hepatic resection for hepatocellular carcinoma associated with liver cirrhosis.

Authors:  Y Kinami; S Takashima; I Miyazaki
Journal:  World J Surg       Date:  1986-04       Impact factor: 3.352

4.  Determination of the extent of feasible hepatic resection from hepatic blood flow.

Authors:  H Mimura; N Takakura; Y Ohno; T Matsuda; H Kin; K Hamazaki; M Tsumura; S Toda; Y Hiraki
Journal:  World J Surg       Date:  1986-04       Impact factor: 3.352

5.  Hepatic function assessment to predict post-hepatectomy liver failure: what can we trust? A systematic review.

Authors:  Federico Tomassini; Mariano C Giglio; Giuseppe De Simone; Roberto Montalti; Roberto I Troisi
Journal:  Updates Surg       Date:  2020-08-04

6.  The preoperative nutritional assessment of surgical patients with hepatic dysfunction.

Authors:  T Higashiguchi; H Yokoi; T Noguchi; Y Kawarada; R Mizumoto; P O Hasselgren
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

7.  Role of surgical treatment for recurrent hepatocellular carcinoma after hepatic resection.

Authors:  Y Nakajima; T Ohmura; J Kimura; T Shimamura; K Misawa; M Matsushita; N Sato; Y Une; J Uchino
Journal:  World J Surg       Date:  1993 Nov-Dec       Impact factor: 3.352

8.  Major hepatic resection. A 25-year experience.

Authors:  H H Thompson; R K Tompkins; W P Longmire
Journal:  Ann Surg       Date:  1983-04       Impact factor: 12.969

9.  Hepatic resection for hepatocellular carcinoma.

Authors:  M Suenaga; A Nakao; A Harada; T Nonami; Y Okada; H Sugiura; S Uehara; H Takagi
Journal:  World J Surg       Date:  1992 Jan-Feb       Impact factor: 3.352

10.  Significance of multidisciplinary therapy for hepatocellular carcinoma.

Authors:  Y Kawarada; T Imai; M Iwata; H Yokoi; T Noguchi; R Mizumoto
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.